This page shows the latest Seroquel news and features for those working in and with pharma, biotech and healthcare.
to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.
for cholesterol drug Crestor (rosuvastatin) and antipsychotic Seroquel XR (quetiapine).
GlobalData analyst Adam Dion said: “ AZ, CNS segment has been bleeding sales as a result of the company losing its patent on Seroquel (quetiapine), a treatment for bipolar disorder.
Zyprexa (olanzapine) and AstraZeneca's Seroquel (quetiapine) - now available generically.
The schizophrenia market has been shrinking in recent years as massively successful antipsychotic medicines such as Lilly's Zyprexa (olanzapine), AstraZeneca/Astellas' Seroquel (quetiapine) and Bristol-Myers Squibb/Otsuka Pharmaceutical's
AstraZeneca sales hit by Seroquel generics. End of patent exclusivity for antipsychotic among key factors dragging down revenues. ... The end of patent protection for Seroquel (quetiapine) in a number of territories put a large dent in AstraZeneca's
More from news
Approximately 3 fully matching, plus 88 partially matching documents found.
For example, patents for Seroquel (AstraZeneca - 2011 revenues of $5.8bn), Zyprexa (Eli Lily - $4.6bn) and Concerta (J&J - $1.3bn) had all expired by May 2012.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
2003 - Gold. Worldfest - Seroquel: The Clever Molecule. 2000 - Finalist Certificate.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...